ask="N/A"
ask_size="N/A"
average_daily_volume="112524"
bid="N/A"
bid_size="N/A"
book_value="0.4440"
change="+0.0024"
change_from_200_day_moving_average="-0.3236"
change_from_50_day_moving_average="-0.0658"
change_from_52_week_high="-1.6276"
change_From_52_week_low="0.2224"
change_in_percent="+0.1224%"
close="1.9624"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.3560"
ebitda="-8.60M"
eps_estimate_current_year="-0.3100"
eps_estimate_next_quarter="-0.0600"
eps_estimate_next_year="-0.3300"
ex_dividend_date="N/A"
float_shares="13184000"
high="1.9700"
high_52_weeks="3.5900"
last_trade_date="2/27/2017"
last_trade_price="1.9624"
last_trade_size="100"
last_trade_time="4:02pm"
low="1.9270"
low_52_weeks="1.7400"
market_capitalization="26.25M"
moving_average_200_day="2.2860"
moving_average_50_day="2.0282"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.0000"
open="1.9600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-14.1542%"
percent_change_from_50_day_moving_average="-3.2457%"
percent_change_from_52_week_high="-45.3370%"
percent_change_from_52_week_low="+12.7816%"
previous_close="1.9600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.4144"
price_per_sales="130.2202"
revenue="201373.00"
shares_outstanding="13379000"
short_ratio="1.1100"
stock_exchange="ASE"
symbol="CANF"
volume="128906"
weeks_range_52="1.7400 - 3.5900"
